These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9504864)

  • 21. Connexins, gap junctions and peripheral neuropathy.
    Kleopa KA; Sargiannidou I
    Neurosci Lett; 2015 Jun; 596():27-32. PubMed ID: 25449862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genes, gene knockouts, and mutations in the analysis of gap junctions.
    Lo CW
    Dev Genet; 1999; 24(1-2):1-4. PubMed ID: 10079505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gap junctions: structure and function (Review).
    Evans WH; Martin PE
    Mol Membr Biol; 2002; 19(2):121-36. PubMed ID: 12126230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel connexin32 mutations cause early onset X-linked Charcot-Marie-Tooth disease.
    Braathen GJ; Sand JC; Bukholm G; Russell MB
    BMC Neurol; 2007 Jul; 7():19. PubMed ID: 17620124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
    Abrams CK; Bennett MV; Verselis VK; Bargiello TA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
    Kyriakoudi S; Sargiannidou I; Kagiava A; Olympiou M; Kleopa KA
    Hum Mol Genet; 2017 May; 26(9):1622-1633. PubMed ID: 28334782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gap junctions: basic structure and function.
    Meşe G; Richard G; White TW
    J Invest Dermatol; 2007 Nov; 127(11):2516-24. PubMed ID: 17934503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of blocked gap junctional intercellular communication in non-genotoxic carcinogenesis.
    Mesnil M; Krutovskikh V; Omori Y; Yamasaki H
    Toxicol Lett; 1995 Dec; 82-83():701-6. PubMed ID: 8597129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.
    Abrams CK; Freidin M; Bukauskas F; Dobrenis K; Bargiello TA; Verselis VK; Bennett MV; Chen L; Sahenk Z
    J Neurosci; 2003 Nov; 23(33):10548-58. PubMed ID: 14627639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connexins and information transfer through glia.
    Bruzzone R; Giaume C
    Adv Exp Med Biol; 1999; 468():321-37. PubMed ID: 10635040
    [No Abstract]   [Full Text] [Related]  

  • 31. Cx32 hemichannel opening by cytosolic Ca2+ is inhibited by the R220X mutation that causes Charcot-Marie-Tooth disease.
    Carrer A; Leparulo A; Crispino G; Ciubotaru CD; Marin O; Zonta F; Bortolozzi M
    Hum Mol Genet; 2018 Jan; 27(1):80-94. PubMed ID: 29077882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gap junctions and tissue business: problems and strategies for developing specific functional reagents.
    Goodenough DA; Musil LS
    J Cell Sci Suppl; 1993; 17():133-8. PubMed ID: 8144689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gap junction channels: new roles in disease.
    Donaldson P; Eckert R; Green C; Kistler J
    Histol Histopathol; 1997 Jan; 12(1):219-31. PubMed ID: 9046057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease.
    Oh S; Ri Y; Bennett MV; Trexler EB; Verselis VK; Bargiello TA
    Neuron; 1997 Oct; 19(4):927-38. PubMed ID: 9354338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular mechanisms of connexin32 mutations associated with CNS manifestations.
    Kleopa KA; Yum SW; Scherer SS
    J Neurosci Res; 2002 Jun; 68(5):522-34. PubMed ID: 12111842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
    Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
    Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression and function of hepatocyte gap junctions after common bile duct ligation in the rat.
    Fallon MB; Nathanson MH; Mennone A; Sáez JC; Burgstahler AD; Anderson JM
    Am J Physiol; 1995 May; 268(5 Pt 1):C1186-94. PubMed ID: 7762611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connexin32 and X-linked Charcot-Marie-Tooth disease.
    Bone LJ; Deschênes SM; Balice-Gordon RJ; Fischbeck KH; Scherer SS
    Neurobiol Dis; 1997; 4(3-4):221-30. PubMed ID: 9361298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X.
    Kleopa KA; Zamba-Papanicolaou E; Alevra X; Nicolaou P; Georgiou DM; Hadjisavvas A; Kyriakides T; Christodoulou K
    Neurology; 2006 Feb; 66(3):396-402. PubMed ID: 16476939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connexin32 is expressed in vascular endothelial cells and participates in gap-junction intercellular communication.
    Okamoto T; Akiyama M; Takeda M; Gabazza EC; Hayashi T; Suzuki K
    Biochem Biophys Res Commun; 2009 May; 382(2):264-8. PubMed ID: 19265674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.